{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:47:22Z","timestamp":1780447642889,"version":"3.54.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Omeros Corporation, Seattle, WA."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The lectin pathway (LP) of complement mediates inflammatory processes linked to tissue damage and loss of function following traumatic brain injury (TBI). LP activation triggers a cascade of proteolytic events initiated by LP specific enzymes called MASPs (for Mannan-binding lectin Associated Serine Proteases). Elevated serum and brain levels of MASP-2, the effector enzyme of the LP, were previously reported to be associated with the severity of tissue injury and poor outcomes in patients with TBI. To evaluate the therapeutic potential of LP inhibition in TBI, we first conducted a pilot study testing the effect of an inhibitory MASP-2 antibody (\u03b1-MASP-2), administered systemically at 4 and 24\u00a0h post-TBI in a mouse model of controlled cortical impact (CCI). Treatment with \u03b1-MASP-2 reduced sensorimotor and cognitive deficits for up to 5 weeks post-TBI. As previous studies by others postulated a critical role of MASP-1 in LP activation, we conducted an additional study that also assessed treatment with an inhibitory MASP-1 antibody (\u03b1-MASP-1). A total of 78 mice were treated intraperitoneally with either \u03b1-MASP-2, or \u03b1-MASP-1, or an isotype control antibody 4\u00a0h and 24\u00a0h after TBI or sham injury. An amelioration of the cognitive deficits assessed by Barnes Maze, prespecified as the primary study endpoint, was exclusively observed in the \u03b1-MASP-2-treated group. The behavioral data were paralleled by a reduction of the lesion size when evaluated histologically and by reduced systemic LP activity. Our data suggest that inhibition of the LP effector enzyme MASP-2 is a promising treatment strategy to limit neurological deficits and tissue loss following TBI. Our work has translational value because a MASP-2 antibody has already completed multiple late-stage clinical trials in other indications and we used a clinically relevant treatment protocol testing the therapeutic mechanism of MASP-2 inhibition in TBI.<\/jats:p>","DOI":"10.1186\/s12974-024-03133-4","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T21:06:19Z","timestamp":1716930379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Inhibition of mannan-binding lectin associated serine protease (MASP)-2 reduces the cognitive deficits in a mouse model of severe traumatic brain injury"],"prefix":"10.1186","volume":"21","author":[{"given":"Domenico","family":"Mercurio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Pischiutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Seminara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Tribuzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Lisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pasetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Bonetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Grazia","family":"De Simoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilhelm","family":"Schwaeble","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadam","family":"Yaseen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Dudler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa R.","family":"Zanier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Fumagalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,28]]},"reference":[{"key":"3133_CR1","doi-asserted-by":"publisher","first-page":"e075049","DOI":"10.1136\/bmjopen-2023-075049","volume":"13","author":"B Guan","year":"2023","unstructured":"Guan B, Anderson DB, Chen L, Feng S, Zhou H. Global, regional and national burden of traumatic brain injury and spinal cord injury, 1990\u20132019: a systematic analysis for the global burden of Disease Study 2019. BMJ Open. 2023;13:e075049.","journal-title":"BMJ Open"},{"key":"3133_CR2","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s13054-016-1318-1","volume":"20","author":"N Stocchetti","year":"2016","unstructured":"Stocchetti N, Zanier ER. Chronic impact of traumatic brain injury on outcome and quality of life: a narrative review. Crit Care. 2016;20:148.","journal-title":"Crit Care"},{"key":"3133_CR3","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.3389\/fnins.2019.01178","volume":"13","author":"V Dinet","year":"2019","unstructured":"Dinet V, Petry KG, Badaut J. Brain-Immune interactions and Neuroinflammation after traumatic brain Injury. Front Neurosci. 2019;13:1178.","journal-title":"Front Neurosci"},{"key":"3133_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12974-018-1066-z","volume":"15","author":"A Hammad","year":"2018","unstructured":"Hammad A, Westacott L, Zaben M. The role of the complement system in traumatic brain injury: a review. J Neuroinflammation. 2018;15:24.","journal-title":"J Neuroinflammation"},{"key":"3133_CR5","doi-asserted-by":"crossref","unstructured":"Neglia L, Fumagalli S, Orsini F, Zanetti A, Perego C, De Simoni M-G. Mannose-binding lectin has a direct deleterious effect on ischemic brain microvascular endothelial cells. J Cereb Blood Flow Metab. 2019;0271678X19874509.","DOI":"10.1177\/0271678X19874509"},{"key":"3133_CR6","doi-asserted-by":"publisher","first-page":"10498","DOI":"10.1073\/pnas.1202588109","volume":"109","author":"D H\u00e9ja","year":"2012","unstructured":"H\u00e9ja D, Kocsis A, Dob\u00f3 J, Szil\u00e1gyi K, Sz\u00e1sz R, Z\u00e1vodszky P, et al. Revised mechanism of complement lectin-pathway activation revealing the role of serine protease MASP-1 as the exclusive activator of MASP-2. Proc Natl Acad Sci USA. 2012;109:10498\u2013503.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3133_CR7","doi-asserted-by":"publisher","first-page":"6132","DOI":"10.4049\/jimmunol.180.9.6132","volume":"180","author":"M Takahashi","year":"2008","unstructured":"Takahashi M, Iwaki D, Kanno K, Ishida Y, Xiong J, Matsushita M, et al. Mannose-binding lectin (MBL)-associated serine protease (MASP)-1 contributes to activation of the lectin complement pathway. J Immunol. 2008;180:6132\u20138.","journal-title":"J Immunol"},{"key":"3133_CR8","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1177\/0271678X18758881","volume":"39","author":"D De Blasio","year":"2019","unstructured":"De Blasio D, Fumagalli S, Orsini F, Neglia L, Perego C, Ortolano F, et al. Human brain trauma severity is associated with lectin complement pathway activation. J Cereb Blood Flow Metab. 2019;39:794\u2013807.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3133_CR9","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1177\/0271678X16647397","volume":"37","author":"D De Blasio","year":"2017","unstructured":"De Blasio D, Fumagalli S, Longhi L, Orsini F, Palmioli A, Stravalaci M, et al. Pharmacological inhibition of mannose-binding lectin ameliorates neurobehavioral dysfunction following experimental traumatic brain injury. J Cereb Blood Flow Metab. 2017;37:938\u201350.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3133_CR10","doi-asserted-by":"publisher","first-page":"1910","DOI":"10.1097\/CCM.0000000000000399","volume":"42","author":"L Longhi","year":"2014","unstructured":"Longhi L, Orsini F, De Blasio D, Fumagalli S, Ortolano F, Locatelli M, et al. Mannose-binding lectin is expressed after clinical and experimental traumatic brain injury and its deletion is protective. Crit Care Med. 2014;42:1910\u20138.","journal-title":"Crit Care Med"},{"key":"3133_CR11","doi-asserted-by":"publisher","first-page":"1484","DOI":"10.1161\/CIRCULATIONAHA.112.103051","volume":"126","author":"F Orsini","year":"2012","unstructured":"Orsini F, Villa P, Parrella S, Zangari R, Zanier ER, Gesuete R, et al. Targeting mannose-binding lectin confers long-lasting protection with a surprisingly wide therapeutic window in cerebral ischemia. Circulation. 2012;126:1484\u201394.","journal-title":"Circulation"},{"key":"3133_CR12","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1089\/neu.2016.4941","volume":"34","author":"M Osthoff","year":"2017","unstructured":"Osthoff M, Walder B, Delhumeau C, Trendelenburg M, Turck N. Association of Lectin Pathway Protein Levels and Genetic Variants Early after Injury with outcomes after severe traumatic brain Injury: a prospective cohort study. J Neurotrauma. 2017;34:2560\u20136.","journal-title":"J Neurotrauma"},{"key":"3133_CR13","doi-asserted-by":"crossref","unstructured":"Mercurio D, Oggioni M, Fumagalli S, Lynch NJ, Roscher S, Minuta D, et al. Targeted deletions of complement lectin pathway genes improve outcome in traumatic brain injury, with MASP-2 playing a major role. Acta Neuropathol Commun. 2020;8(1):174.","DOI":"10.1186\/s40478-020-01041-1"},{"key":"3133_CR14","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12974-016-0684-6","volume":"13","author":"F Orsini","year":"2016","unstructured":"Orsini F, Chrysanthou E, Dudler T, Cummings WJ, Takahashi M, Fujita T, et al. Mannan binding lectin-associated serine protease-2 (MASP-2) critically contributes to post-ischemic brain injury independent of MASP-1. J Neuroinflammation. 2016;13:213.","journal-title":"J Neuroinflammation"},{"key":"3133_CR15","doi-asserted-by":"crossref","unstructured":"Ali YM, Carnell GW, Fumagalli S, Mercurio D, Seminara S, Lynch NJ et al. Inhibition of the lectin pathway of complement activation reduces Acute Respiratory Distress Syndrome severity in a mouse model of SARS-CoV-2 infection. J Infect Dis. 2023;jiad462.","DOI":"10.1093\/infdis\/jiad462"},{"key":"3133_CR16","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.bja.2020.08.027","volume":"126","author":"F Moro","year":"2021","unstructured":"Moro F, Fossi F, Magliocca A, Pascente R, Sammali E, Baldini F, et al. Efficacy of acute administration of inhaled argon on traumatic brain injury in mice. Br J Anaesth. 2021;126:256\u201364.","journal-title":"Br J Anaesth"},{"key":"3133_CR17","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1089\/neu.2006.0011","volume":"24","author":"DL Brody","year":"2007","unstructured":"Brody DL, Mac Donald C, Kessens CC, Yuede C, Parsadanian M, Spinner M, et al. Electromagnetic controlled cortical impact device for Precise, graded experimental traumatic brain Injury. J Neurotrauma. 2007;24:657\u201373.","journal-title":"J Neurotrauma"},{"key":"3133_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.trsl.2022.06.018","volume":"249","author":"JD Belcher","year":"2022","unstructured":"Belcher JD, Nguyen J, Chen C, Abdulla F, Conglin R, Ivy ZK, et al. MASP-2 and MASP-3 inhibitors block complement activation, inflammation, and microvascular stasis in a murine model of vaso-occlusion in sickle cell disease. Transl Res. 2022;249:1\u201312.","journal-title":"Transl Res"},{"key":"3133_CR19","doi-asserted-by":"publisher","first-page":"fcac036","DOI":"10.1093\/braincomms\/fcac036","volume":"4","author":"F Moro","year":"2022","unstructured":"Moro F, Pischiutta F, Portet A, Needham EJ, Norton EJ, Ferdinand JR, et al. Ageing is associated with maladaptive immune response and worse outcome after traumatic brain injury. Brain Commun. 2022;4:fcac036.","journal-title":"Brain Commun"},{"key":"3133_CR20","doi-asserted-by":"crossref","first-page":"e2744","DOI":"10.21769\/BioProtoc.2744","volume":"8","author":"MW Pitts","year":"2018","unstructured":"Pitts MW. Barnes Maze Procedure for Spatial Learning and memory in mice. Bio Protoc. 2018;8:e2744.","journal-title":"Bio Protoc"},{"key":"3133_CR21","doi-asserted-by":"crossref","unstructured":"Bonetto V, Pasetto L, Lisi I, Carbonara M, Zangari R, Ferrari E, et al. Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations. Front Immunol. 2022;13:1070379.","DOI":"10.3389\/fimmu.2022.1070379"},{"key":"3133_CR22","doi-asserted-by":"publisher","first-page":"288","DOI":"10.3389\/fimmu.2017.00288","volume":"8","author":"S Fumagalli","year":"2017","unstructured":"Fumagalli S, Perego C, Zangari R, De Blasio D, Oggioni M, De Nigris F, et al. Lectin pathway of complement activation is Associated with vulnerability of atherosclerotic plaques. Front Immunol. 2017;8:288.","journal-title":"Front Immunol"},{"key":"3133_CR23","doi-asserted-by":"publisher","first-page":"7523","DOI":"10.1073\/pnas.1101748108","volume":"108","author":"WJ Schwaeble","year":"2011","unstructured":"Schwaeble WJ, Lynch NJ, Clark JE, Marber M, Samani NJ, Ali YM, et al. Targeting of mannan-binding lectin-associated serine protease-2 confers protection from myocardial and gastrointestinal ischemia\/reperfusion injury. Proc Natl Acad Sci USA. 2011;108:7523\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3133_CR24","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1016\/S1474-4422(17)30371-X","volume":"16","author":"AIR Maas","year":"2017","unstructured":"Maas AIR, Menon DK, Adelson PD, Andelic N, Bell MJ, Belli A, et al. Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research. Lancet Neurol. 2017;16:987\u20131048.","journal-title":"Lancet Neurol"},{"key":"3133_CR25","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1089\/neu.2022.0320","volume":"40","author":"A Mikoli\u0107","year":"2023","unstructured":"Mikoli\u0107 A, Steyerberg EW, Polinder S, Wilson L, Zeldovich M, von Steinbuechel N, et al. Prognostic models for global functional outcome and post-concussion symptoms following mild traumatic brain Injury: a collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) Study. J Neurotrauma. 2023;40:1651\u201370.","journal-title":"J Neurotrauma"},{"key":"3133_CR26","doi-asserted-by":"publisher","first-page":"113865","DOI":"10.1016\/j.expneurol.2021.113865","volume":"346","author":"J Pedragosa","year":"2021","unstructured":"Pedragosa J, Mercurio D, Oggioni M, Marquez-Kisinousky L, de Simoni M-G, Planas AM. Mannose-binding lectin promotes blood-brain barrier breakdown and exacerbates axonal damage after traumatic brain injury in mice. Exp Neurol. 2021;346:113865.","journal-title":"Exp Neurol"},{"key":"3133_CR27","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1096\/fj.201601306R","volume":"31","author":"S Yaseen","year":"2017","unstructured":"Yaseen S, Demopulos G, Dudler T, Yabuki M, Wood CL, Cummings WJ, et al. Lectin pathway effector enzyme mannan-binding lectin-associated serine protease-2 can activate native complement C3 in absence of C4 and\/or C2. FASEB J. 2017;31:2210\u20139.","journal-title":"FASEB J"},{"key":"3133_CR28","doi-asserted-by":"publisher","first-page":"13445","DOI":"10.1073\/pnas.1406849111","volume":"111","author":"SE Degn","year":"2014","unstructured":"Degn SE, Kjaer TR, Kidmose RT, Jensen L, Hansen AG, Tekin M, et al. Complement activation by ligand-driven juxtaposition of discrete pattern recognition complexes. Proc Natl Acad Sci U S A. 2014;111:13445\u201350.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-024-03133-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-024-03133-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-024-03133-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T14:55:16Z","timestamp":1732114516000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-024-03133-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3133"],"URL":"https:\/\/doi.org\/10.1186\/s12974-024-03133-4","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,28]]},"assertion":[{"value":"30 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The project was approved by the Italian Ministry of Health with the codes No. 9F5F5.148 (approval number 80\/2020-PR) and No. 9F5F5.206 (approval number 117\/2022-PR).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors agreed on the content of this manuscript before its submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SY and TD are employees of Omeros Corporation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"141"}}